Physician profile
Mark J Mullen
NPI 1679581870
$837.85
in general payments reported to CMS, 2019-2025
16 companies · $65.48 in 2025
The $65.48 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $283 · 2020: $136 · 2021: $77.39 · 2022: $77.49 · 2023: $84.50 · 2024: $114 · 2025: $65.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $264.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $157.62 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Amgen INC. | $132.00 | 2019-2021 | |
| Pfizer INC. | $93.60 | 2020-2022 | |
| Amarin Pharma, INC. | $88.94 | 2019-2021 | |
| Sanofi Pasteur INC. | $59.28 | 2019-2025 | |
| Glaxosmithkline, LLC. | $51.23 | 2019-2023 | Arexvy, Shingrix |
| Abbott Laboratories | $45.05 | 2021-2025 | Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $39.15 | 2022-2024 | |
| Exact Sciences Corporation | $37.05 | 2023-2024 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $36.95 | 2019-2021 | |
| Dexcom, INC. | $23.92 | 2024 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals LP | $16.01 | 2019 | |
| Lundbeck LLC | $15.95 | 2024 | Rexulti |
| Abbvie INC. | $14.33 | 2023 | |
| Janssen Pharmaceuticals, INC | $14.05 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $12.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Mullen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.